Skip to main content

You are currently viewing a beta version of this site; please send improvements to contact@openomb.org.

International narcotics control

Schedules

TAFS: 011-1022S-019 2022/2023 - International narcotics control

Iterations:
Adjustment authority: No
Reporting categories: No
Bureau: Other
Line #SplitDescriptionAmountFootnotes
1121BA: Disc: Approps transferred from other accounts$234,053,899.00
1134BA: Disc: Appropriations precluded from obligation-$1,101,108,101.00 See footnotes below
Footnotes for line 1134:

B1: Amount on line 1134 has been adjusted pursuant to OMB Bulletin 21-05 and Section A-11 120.41

1151BA: Disc: Appropriations:Antic nonexpend trans net$1,101,108,101.00
1740BA: Disc: Spending auth:Antic colls, reimbs, other$4,000,000.00
1920Total budgetary resources avail (disc. and mand.)$238,053,899.00
6001Category A -- 1st quarter$204,276,000.00
6103INCLE Reimbursements$4,000,000.00
6110Lump Sum$29,777,899.00
6190Total budgetary resources available$238,053,899.00 See footnotes below
Footnotes for line 6190:

A1: Pursuant to 31 U.S.C. 1553(b), not to exceed one percent of the total appropriations for this account is apportioned for the purpose of paying legitimate obligations related to canceled appropriations.

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
Pursuant to 31 U.S.C. 1553(b), not to exceed one percent of the total appropriations for this account is apportioned for the purpose of paying legitimate obligations related to canceled appropriations.
B1
Amount on line 1134 has been adjusted pursuant to OMB Bulletin 21-05 and Section A-11 120.41

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.